A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)-Reference-Cited by-同舟云学术

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

Published:2019-09-27 Issue:9 Volume:14 Page:e0222650
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mussini Cristina^ORCID,Roncaglia Enrica,Borghi Vanni,Rusconi Stefano^ORCID,Nozza Silvia,Cattelan Anna Maria,Segala Daniela,Bonfanti Paolo,Di Biagio Antonio,Barchi Enrico,Focà Emanuele^ORCID,Degli Antoni Anna,Bonora Stefano,Francisci Daniela,Limonta Silvia^ORCID,Antinori Andrea,D’Ettorre Gabriella,Maggiolo Franco

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013;Late presenters working group in COHERE in EuroCoord;Euro Surveill,2015

2. The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy;A Calmy;Clin Infect Dis,2018

3. Late Presentation of HIV Infection in the Netherlands: Reasons for Late Diagnoses and Impact on Vocational Functioning;SEM van Opstal;AIDS Behav,2018

4. Prospective, randomized, open label trial of efavirenz vs lopinavir/ritonavir in HIV+ treatment-naive subjects with CD4+<200 cells/mm3 in Mexico;J Sierra-Madero;J Acquir Immune Defic Syndr,2010

5. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial;for the Advanz Study Group;AIDS Res Hum Retroviruses,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review;Infection;2023-07-20

2. Immune response to ART initiation in advanced HIV infection;HIV Medicine;2023-02-15

3. A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China;Frontiers in Immunology;2023-01-09

4. Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study;Journal of Clinical Medicine;2022-08-25

5. Comparison of the Efficacy and Safety of a Doravirine-Based, Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-04-20